TNFA Market Cap History — TNF Pharmaceuticals Capitalization Over Time

As of 4/4/2025 TNF Pharmaceuticals has a market cap of 3.76 million. Investors often follow the TNFA market cap history to compare the size of the company over time.

This page shows TNFA market capitalization trends over time, with 2 market cap datapoints presented, dating back to 5/12/2024.

Quick links: Market Cap History Table  |  Market Cap History Chart  |  About TNF Pharmaceuticals
TNFA Market Cap History



Below is a table of the TNFA market cap history going back to 5/12/2024:

Date TNFA Market Cap
5/12/20245.77M
4/4/20253.76M

Also see: TNFA Shares Outstanding History
and TNFA YTD Return
TNFA Historical Market Cap:
-38.89% CAGR
TNFA Historical Market Cap: +-38.89% CAGR

Mouse over chart for data details
5/12/20244/4/2025
TNF Pharmaceuticals, Inc., formerly MyMD Pharmaceuticals, Inc., is a clinical-stage biopharmaceutical company focused on developing novel therapies for age-related diseases and autoimmune and inflammatory conditions. It is focused on developing and commercializing two therapeutic platforms based on well-defined therapeutic targets: MYMD-1 and Supera-CBD. MYMD-1 is a drug platform based on a clinical-stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro-inflammatory cell signaling cytokines. MYMD-1 is being developed to treat diseases and disorders marked by acute or chronic inflammation. We show 2 historical shares outstanding datapoints in our TNFA shares outstanding history coverage, used to compute TNFA market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing TNFA market cap history over the course of time is important for investors interested in comparing TNFA's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of TNFA versus a peer is one thing; comparing TNFA market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like TNFA can fluctuate over the course of history. With this page we aim to empower investors researching TNFA by allowing them to research the TNFA market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree TNFA Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap
TNF Pharmaceuticals (TNFA) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

TNGX Market Cap History
TNON Market Cap History
TNXP Market Cap History
TNYA Market Cap History
TOCA Market Cap History
TOI Market Cap History
TORC Market Cap History
TPIV Market Cap History
TPST Market Cap History
TPTX Market Cap History
More Healthcare companies »
 

TNFA Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2026, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.